Ascendis Pharma A/S (ASND)
229.25
+1.01
(+0.44%)
USD |
NASDAQ |
Apr 02, 16:00
229.15
-0.10
(-0.04%)
After-Hours: 20:00
Ascendis Pharma SG&A Expense (Semi Annual)
SG&A Expense (Semi Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Semi Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Semi Annual) Benchmarks
| Novo Nordisk A/S | -- |
| DBV Technologies SA | -- |
| Evaxion AS | 0.00 |
| Bicycle Therapeutics Plc | -- |
| Biodexa Pharmaceuticals Plc | 3.292M |